From shifts in merger review to significant abuse of dominance fines from the European Commission, we round up the most important recent events in the antitrust space that life sciences companies should be aware of. Mergers: EU call-in powers and FDI …

… key growth driver for Indian pharma companies. Sales force expansion, improved productivity … 10% in FY2025. The operating profit margins (OPM) of ICRA’s …

New Delhi: The Indian pharmaceutical sector is expected to achieve 7-9 per cent revenue growth in FY 2026, driven by strong domestic and European demand, despite a significant slowdown in its US market, a report said on Thursday. Ratings agency ICRA, in a …

… latter category, several big pharma companies are implicated. Eli Lilly … warning letters sent to pharma companies. Many companies on … A report by non-profit Public Citizen backs this … and Gray said that pharmaceutical companies “face significant uncertainty …

… of cross-border disruptions drugmakers experienced during the … large investment amounts drugmakers have pledged include … reshore manufacturing. But drugmakers have told the Trump … their profits, analysts say. Morningstar analysts estimated large drugmakers …

… Barratt Redrow delivered annual profits ahead of forecasts despite … after a string of drugmakers cancelled projects worth nearly … , a former executive at drugmaker GSK, said the country … announcements by three large pharma companies to scrap or pause …

… -profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies …

… reported a 15% jump in profits for the 12 months to … period. NEWSPAPER ROUND UP Big pharmaceutical companies have ditched or paused nearly … thrown into disarray, after US drugmaker MSD's shock announcement …

… 23, 2025: Drug Manufacturers Seventeen pharmaceutical companies received letters from the Trump … strategies to maintain competitiveness and profitability. Innovations and Adaptations: Manufacturers might …

… and primary goods, telecommunications firms, pharmaceutical companies, the stock exchange, and cosmetics … continuing production, even with minimal profits, to preserve their inherited craft …